High prevalence of radiological vertebral fractures in HIV-infected males

Endocrine

Volumn 41, Issue 3, 2012, Pages 512-517

  Torti, Carlo ^a   Mazziotti, Gherardo ^b,c   Soldini, Pier Antonio ^b   Focà, Emanuele ^a   Maroldi, Roberto ^b   Gotti, Daria ^a   Carosi, Giampiero ^a   Giustina, Andrea ^b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c CARLO POMA HOSPITAL   (Italy)

Author keywords

Antiretroviral therapy; HIV; Osteoporosis; Vertebral fracture

Indexed keywords

2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; ANTIRETROVIRUS AGENT; INSULIN; METFORMIN; PROTEINASE INHIBITOR; RITONAVIR; TENOFOVIR;

ADULT; AGE DISTRIBUTION; AGED; ANTIVIRAL THERAPY; ARTICLE; BODY MASS; COMORBIDITY; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DATA ANALYSIS SOFTWARE; DIABETES MELLITUS; DIGITAL IMAGING; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EXPOSURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE STUDY; THORAX RADIOGRAPHY; VERTEBRA FRACTURE;

EID: 84862657388     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-011-9586-7     Document Type: Article

References (30)

1. A.D. Gutierrez, A. Balasubramanyam, Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management. Endocrine (2011). doi:10.1007/s12020-011-9565-7
2. C. Gazzaruso, R. Bruno, A. Garzaniti et al., Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome. J. Hypertens. 21(7), 1377-1382 (2003)
3. R. Bruno, C. Gazzaruso, P. Sacchi et al., High prevalence of metabolic syndrome among HIV-infected patients: link with the cardiovascular risk. J. Acquir. Immune Defic. Syndr. 31(3), 363-365 (2002) (Pubitemid 35278640)
4. P. Sambrook, C. Cooper, Osteoporosis. Lancet 367(9527), 2010-2018 (2006) (Pubitemid 43867702)
5. J.M. Fakruddin, J. Laurence, HIV-1 Vpr enhances production of receptor of activated NF-kappaB ligand (RANKL) via potentiation of glucocorticoid receptor activity. Arch. Virol. 150(1), 67-78 (2005) (Pubitemid 40171950)
6. D. Gibellini, E. de Crignis, C. Ponti et al., HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFalpha activation. J. Med. Virol. 80(9), 1507-1514 (2008)
7. T.T. Brown, R.B. Qaqish, Antiretroviral therapy and the prevalence of osteopenia and ostoporosis: a meta-analytic review. AIDS 20, 2165-2174 (2006) (Pubitemid 44684707)
8. B. Young, C.N. Dao, K. Buchacz, R. Baker, J.T. Brooks, Increased rates of bone fracture among HIV-infected persons in the HIV outpatient study (HOPS) compared with the US general population, 2000-2006. Clin. Infect. Dis. 52(8), 1061-1068 (2011)
9. J.A. Womack, J.L. Goulet, C. Gibert, Increased risk of fragility fractures among HIV infected compared to uninfected male. PLoS ONE 6(2), e17217 (2011)
10. V.A. Triant, T.T. Brown, H. Lee, S.K. Grinspoon, Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J. Clin. Endocrinol. Metab. 93, 3499-3504 (2008)
11. J.H. Arnsten, R. Freeman, A.A. Howard et al., Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS 21(5), 617-623 (2007)
12. P. Vestergaard, Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a metaanalysis. Osteoporos. Int. 18(4), 427-444 (2007) (Pubitemid 46354916)
13. G. Mazziotti, A. Bianchi, S. Bonadonna et al., Prevalence of vertebral fractures in men with acromegaly. J. Clin. Endocrinol. Metab. 93(12), 4649-4655 (2008)
14. K.E. Ensrud, J.T. Schousboe, Vertebral fractures. N. Engl. J. Med. 364, 1634-1642 (2011)
15. A. Angeli, G. Guglielmi, A. Dovio et al., High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone 39(2), 253-259 (2006) (Pubitemid 43870263)
16. M. Grigoryan, A. Guermazi, F.W. Roemer, P.D. Delmas, H.K. Genant, Recognizing and reporting osteoporotic vertebral fractures. Eur. Spine J. 12, S104-S112 (2003) (Pubitemid 37409928)
17. G. Mazziotti, E. Canalis, A. Giustina, Drug-induced osteoporosis: mechanisms and clinical implications. Am. J. Med. 123(10), 877-884 (2010)
18. H.K. Genant, M. Jergas, L. Palermo et al., Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. The Study of Osteoporotic Fractures Research Group. J. Bone Miner. Res. 11(7), 984-996 (1996) (Pubitemid 26200050)
19. J.A. Kanis, E.V. McCloskey, H. Johansson, et al., Case finding for the management of osteoporosis with FRAX®-assessment and intervention thresholds for the UK. Osteoporos. Int. 20, 449-502 (2009)
20. WHO, Fracture Risk Assessment Tool. Available at: http://www.shef.ac.uk/ FRAX
21. N.B. Khazai, G.R. Beck Jr, G.E. Umpierrez, Diabetes and fractures: an overshadowed association. Curr. Opin. Endocrinol. Diabetes Obes. 16, 435-445 (2009)
22. S.K. Grinspoon, A. Carr, Cardiovascular risk and body fat abnormalities in HIV-infected adults. N. Engl. J. Med. 352, 48-62 (2005) (Pubitemid 40075680)
23. I. Kanazawa, T. Yamaguchi, M. Yamamoto, M. Yamauchi, S. Yano, T. Sugimoto, Combination of obesity with hyperglycemia is a risk factor for the presence of vertebral fractures in type 2 diabetic men. Calcif. Tissue Int. 83, 324-331 (2008)
24. C. De Laet, J.A. Kanis, A. Ode0n et al., Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos. Int. 16, 1330-1338 (2005) (Pubitemid 41532085)
25. M. Iki , J. Tamaki, Y. Fujita et al., Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study. Osteoporos. Int. (2011). doi:10.1007/s00198-011-1733-8
26. M.P. Dubè, Disorders of glucose metabolism in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 31(6), 1467-1475 (2000)
27. T.T. Brown, M.D. Ruppe, R. Kassner et al., Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia. J. Clin. Endocrinol. Metab. 89(3), 1200-1206 (2004) (Pubitemid 38368413)
28. D.M. Wunder, N.A. Bersinger, C.A. Fux et al., Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy. Antivir. Ther. 12, 261-265 (2007) (Pubitemid 46569911)
29. J.E. Gallant, S. Staszewski, A.L. Pozniak et al., Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naïve patients: a 3-year randomized trial. JAMA 292(2), 191-201 (2004) (Pubitemid 38917996)
30. G.A. McComsey, D. Kitch, E.S. Daar et al., Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarateemtricitabine along with efavirenz or atazanavir-ritonavir: AIDS Clinical Trials Group A5224s, a substudy of ACTG A5202. J. Infect. Dis. 203(12), 1791-1801 (2011)